Network Grants  
Ongoing Cancer Grants
  Recent Publications From Funded Grants  
:: Germ cell-specific heat shock protein 70-2 is expressed in cervical carcinoma and is involved in the growth, migration, and invasion of cervical cells
:: Identification of Potential Serum Biomarkers of Glioblastoma: Serum Osteopontin Levels Correlate with Poor Prognosis
:: Clinical significance of phosphatidyl inositol synthase overexpression in oral cancer
:: Beyond HPV: oncomirs as new players in cervical cancer
Ongoing Cancer Grants
  Project Title Investigator/s Budget (Rs. In Lakhs) Date of Sanction Duration - years
1. Cytomodulins in oral cancer therapy. Dr. D. Karunagaran
IIT, Chennai.
43.60 02.02.2009 3
2. Loss of heterozygosity on specific chromosomal arms and influence of single nucleotide polymorphisms in XRCC1and XPD genes in oral and esophageal cancers induced by raw betel-nut in Meghalaya. Dr. Anupam Chatterjee
NEHU, Shillong.
18.63 29.06.2009 3
3. Epigenetic mechanisms in Ovarian Cancer progression. Dr. Sharmila A Bapat
NCCS, Pune.
43.99 29.06.2009 3
4. Comparative Proteomic and Transcriptomic Analyses of PEPCK under the influence of Flemingia vestita-derived Phytoestrogen (Genistein). Dr. Bidyadhar Das
NEHU, Shillong.
176.40 03.08.2009 3
5. Neuroendocrine-Immune interactions in mammary tumorigenesis. Dr. S. Thyagarajan
SRM University, Tamil Nadu.
40.25 19.08.2009 3
6. Gene mutations in patients with chronic pancreatitis and their role in pathogenesis of malignant transformation. Dr. Anoop Saraya
AIIMS, New Delhi.
25.11 24.08.2009 3
7. Silencing of MTA1 gene as a strategy to inhibit tumor angiogenesis and metastasis; Role in breast cancer therapy. Prof. Bharathi P. Salimath
University of Mysore, Mysore.
52.31 01.09.2009 3
8. Study on the chemopreventive response of Dolastatin, a mollusc linear peptide of Indian Ocean origin in experimental colon cancer. Dr. S. N. Sanyal
Panjab University, Chandigarh
54.25 01.09.2009 3
9. Hypoxia and p53-HIC1 axis in stemness of glial tumors and cell lines. Dr. Parthaprasad Chattopadhyay
AIIMS, New Delhi  
50.51 01.09.2009 3
10. Coordinated role of SMAR1 and p53 in tumorigenesis and apoptosis. Dr. Samit Chattopadhyay
NCCS, Pune.
30.00 01.09.2009 3
11. To study frequency and load of Human Papilloma Virus (HPV) in benign, pre-malignant (dysplastic) and malignant esophageal squamous epithelium by immunohistochemistry and real time PCR. Dr. Kim Vaiphei
PGIMER, Chandigarh.
15.52 15.09.2009 2
12. Functional genomic delineation of convolutions in Wnt signaling pathway for gastric cancer diagnostics. Dr. G. Kumaresan
Madurai Kamaraj University, Madurai.
27.71 17.09.2009 3
13. Development of folate receptor - mediated system for targeted delivery of curcumin in cancer cells. Dr. B. C. Das
ICPO, Noida.
58.02 30.12.2009 3
14. Exploring the potential of TF antigen binding property of lectin from Sclerotium rolfsii for anticancer effect. Dr. Shashikala R. Inamdar
Karnatak University, Dharwad.
32.74 16.02.2010 3
15. Identification of biomarkers for thyroid malignancies in FNACs. Dr. K. Sujathan
RCC, Thiruvananthapuram.
29.56 01.03.2010 2
16. Immunogenetic profile of nasopharyngeal cancer in a high-prevalence region of Northeast India. Dr. Sunita Saxena
Safdarjang Hospital, New Delhi.
53.60 03.03.2010 3
17. Assessment of therapeutic response of radiolabeled anti CD20 antibodies 131Iodine Rituximab & 90Yttrium Rituximab in diffuse large B cell non-Hodgkin's lymphoma. Prof. Arun Malhotra
AIIMS, New Delhi.
65.99 17.03.2010 3
18. Internal Ribosome Entry Site (IRES) mediated expression of endogenously produced carboxy-terminal domain of Connexin 43 (CT-Cx43): Status of expression in the breast cancer. Dr. Mahboob Ul Hussain
The University of Kashmir, J&K.
27.30 22.03.2010 3
19. Evaluation of the potential of two monoclonal antibodies for treatment of androgen-independent prostatic carcinomas. Prof. G. P. Talwar
TRF, New Delhi.
62.31 25.03.2010 3
20. Role of small molecule inhibitor(s) as targeted therapy in pancreatic and prostate cancers using in vitro and in vivo models. Dr. Surajit Sinha
IACS, Kolkata.
39.56 29.03.2010 3
21. Development of a DNA MGBL as a Radioprotector: Molecular events in the modulation of Ionization radiation induced genomic instability in vitro and in vivo. Dr. Vibha Tandon
University of Delhi, Delhi.
42.72 05.05.2010 3
22. Design, synthesis and identification of phosphodiesterase 4 (PDE4) inhibitors possessing improved safety profile. Dr. Manojit Pal
ILSc, Hyderabad.
24.99 05.05.2010 1
23. Embryonic zebrafish as a model system to study the expression and role of breast tumour kinase (brk/ptk6). Dr. Anil Kumar Challa
ILSc, Hyderabad.
39.92 05.05.2010 3
24. Evaluate the mechanism of resveratrol mediated apoptosis in cigarette smoke induced breast cancer. Dr. Chanakaya Nath Kundu
KIIT University, Bhubaneswar.
34.52 20.05.2010 3
25. Isolation, Characterization of Gliomasphere forming cells from Glioblastoma Multiforme: Correlation with Prognostic Factors and Treatment Outcome. Dr. Srinivas G
SCTIMST, Thiruvananthapuram.  
32.84 26.07.2010   2
26. Proteomic Profiling of squamous cell carcinoma of Esophagus. Dr. T. S. Keshava Prasad
IOB, Bangalore.
38.20 29.09.2010 2
27. Investigating the role of P21 activated kinase 1 (Pak1) signaling in pancreatic adenocarcinoma (PDAC). Dr. Rayala Suresh Kumar
IIT, Chennai.
74.69 31.01.2011 3
28. Development of HPV 18 chimaeric vaccine candidate. Dr. Neeta Singh
AIIMS, New Delhi.
23.85 03.02.2011 2
29. Expression of miR-200 family, miR-205 and cell surface proteins as markers of metastasis in thyroid tumors using real-time PCR and immunohistochemical analysis. Dr. Rekha Pai
CMC, Vellore.
19.74 16.03.2011 2
30. Molecular basis of chemopreventive agent carvone: NFҝB as a potential target in 1,2-dimethyhydrazine-induced colon carcinogenesis. Dr. N. Nalini
AU, Tamilnadu.
27.98 21.02.2011 3
31. Development of cancer researcher database for India. Dr. Renu Goel
IOB, Bangalore.
13.58 28.02.2011 1
32. Study on the significance of Micro-RNA expression pattern in oral carcinoma. Phase-II: Validation of microarray results and assessment of its prognostic significance. Dr. S. Kannan
RCC, Thiruvananthapuram.
42.61 16.03.2011 3
33. A proteomic investigation to identify candidate biomarkers for Acute Liver Failure and Acute on Chronic Liver Failure using high resolution mass spectrometry. Dr. S. K. Sarin
ILBS, New Delhi.
86.30 16.03.2011 3
34. Identifying surface marker signature of oral cancer stem cells to develop a prognosis marker for oral squamous cell carcinoma using peptide-based CSC detection. Dr. Tessy Thomas Maliekal
RGCBT, Thiruvananthapuram.
72.28 18.03.2011 3
35. Sequence dependent molecular action of ZD6474 with paclitaxel and radiation in progression and treatment of breast cancer. Dr. Mahitosh Mandal
IIT, Kharagpur.
31.50 28.03.2011 3
36. Glioma serum biomarker discovery through proteomic approaches. Dr. Kumaravel Somasundaram
IISc, Bangalore.
83.10 28.03.2011 3
37. A yeast based screen for discovery of novel sirtuin inhibitors as anti-cancer agents. Dr. Devyani Haldar
ILSc, Hyderabad.
32.52 28.03.2011 3
38. A chemical biology approach to discover Allosteric Modulators of Sirtuins and to understand their mode of action. Dr. Prabhat Arya
ILSc, Hyderabad.  
29.60 28.03.2011 3
39 Development of therapeutic peptides from small proteoglycan luecine rich repeat family for the inhibition of tumor angiogenesis. Prof. K. N. Sulochana
VRF, Chennai.
19.16 30.06.2011 3
40. Salivary transcriptome and proteome for the diagnosis and prognosis of oral cancer Dr. M A Kuriakose
MSCC, Bangalore
59.51 12.9.2011 3
41. Designing of cost effective, quick and easy visualization method for detection of CML, AML and ALL leukemia patients using Molecular Beacons. Prof. Daman Saluja
Dr. B. R. Ambedkar Center for Biomedical Research, Delhi.
42.19 28.03.2011 3
42. A comprehensive understanding of the Nasopharyngeal Carcinoma (NPC) in the North-Eastern Region of India Dr. Ashok Kumar Das
Dr. Bhubaneshwar Borooah Cancer Institute, Guwahati, (Assam)
62.53 25-03-2011 3
43. -- Prof. Sankar Kumar Ghosh Assam University
Silchar Assam
177.03 -- 3
44. -- Dr.Tathagata Choudhuri
Institute of Life Sciences, Bhubaneswar
332.05 -- 3
45.   Dr. Ravi Kannan
Director Cachar Cancer Hospital & Research Centre, Meherpur, Silchar
33.31   3
46. -- Dr. Narender K. Mehra
AIIMS, New Delhi
64.23 -- 3
47.   Civil Hospital
Azwal, Mizoram
21.78 -- 3
48. -- Dr Debroy
Civil Hospital, Dimapur, Nagaland
21.78 -- 3
49. -- Dr Tsring
Arunachal State Hospital, Naharlagun, Arunachal Pradesh
21.78 -- 3
50. -- Guwahati Medical College
1.65 -- 3
51.   Regional Institute of Medical Sciences, Imphal 21.78   3
52. -- DBT Co-ordination Cell
ILS, Bhubaneshwar
63.20 -- 3
India Cancer Research Database has been developed by the Institute of Bioinformatics with funding from the Department of Biotechnology, Government of India.